1h Free Analyst Time
The global antimicrobial therapeutics market is forecasted to grow by USD 65.67 billion during 2025-2030, accelerating at a CAGR of 6.1% during the forecast period. The report on the global antimicrobial therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating global prevalence of antimicrobial resistance and multi-drug resistant pathogens, accelerated regulatory approvals and strategic pipeline enhancements, integration of ai and precision medicine platforms in drug discovery.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global antimicrobial therapeutics market is segmented as below:
By Application
- Antiviral
- Antibacterial
- Antifungal
- Antiparasitic
By End-User
- Pharmacies
- Hospitals and clinics
- Research and academic institutes
By Route Of Administration
- Oral
- Intravenous
- Topical
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
The report on the global antimicrobial therapeutics market covers the following areas:
- Global antimicrobial therapeutics market sizing
- Global antimicrobial therapeutics market forecast
- Global antimicrobial therapeutics market industry analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Antimicrobial Therapeutics Market 2020 - 2024
- Historic Market Size - Data Table on Global Antimicrobial Therapeutics Market 2020 - 2024 ($ million)
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on global antimicrobial therapeutics market
6.2 Impact of geopolitical conflicts on global antimicrobial therapeutics market
6.2 Impact of geopolitical conflicts on global antimicrobial therapeutics market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Application
8.1 Market segments
- Chart on Application - Market share 2025-2030 (%)
- Data Table on Application - Market share 2025-2030 (%)
- Chart on Comparison by Application
- Data Table on Comparison by Application
- Chart on Antiviral - Market size and forecast 2025-2030 ($ million)
- Data Table on Antiviral - Market size and forecast 2025-2030 ($ million)
- Chart on Antiviral - Year-over-year growth 2025-2030 (%)
- Data Table on Antiviral - Year-over-year growth 2025-2030 (%)
- Chart on Antibacterial - Market size and forecast 2025-2030 ($ million)
- Data Table on Antibacterial - Market size and forecast 2025-2030 ($ million)
- Chart on Antibacterial - Year-over-year growth 2025-2030 (%)
- Data Table on Antibacterial - Year-over-year growth 2025-2030 (%)
- Chart on Antifungal - Market size and forecast 2025-2030 ($ million)
- Data Table on Antifungal - Market size and forecast 2025-2030 ($ million)
- Chart on Antifungal - Year-over-year growth 2025-2030 (%)
- Data Table on Antifungal - Year-over-year growth 2025-2030 (%)
- Chart on Antiparasitic - Market size and forecast 2025-2030 ($ million)
- Data Table on Antiparasitic - Market size and forecast 2025-2030 ($ million)
- Chart on Antiparasitic - Year-over-year growth 2025-2030 (%)
- Data Table on Antiparasitic - Year-over-year growth 2025-2030 (%)
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
9 Market Segmentation by End-user
9.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- Chart on Pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Pharmacies - Year-over-year growth 2025-2030 (%)
- Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
- Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
- Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
- Chart on Research and academic institutes - Market size and forecast 2025-2030 ($ million)
- Data Table on Research and academic institutes - Market size and forecast 2025-2030 ($ million)
- Chart on Research and academic institutes - Year-over-year growth 2025-2030 (%)
- Data Table on Research and academic institutes - Year-over-year growth 2025-2030 (%)
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- Chart on Intravenous - Market size and forecast 2025-2030 ($ million)
- Data Table on Intravenous - Market size and forecast 2025-2030 ($ million)
- Chart on Intravenous - Year-over-year growth 2025-2030 (%)
- Data Table on Intravenous - Year-over-year growth 2025-2030 (%)
- Chart on Topical - Market size and forecast 2025-2030 ($ million)
- Data Table on Topical - Market size and forecast 2025-2030 ($ million)
- Chart on Topical - Year-over-year growth 2025-2030 (%)
- Data Table on Topical - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ million)
- Data Table on Israel - Market size and forecast 2025-2030 ($ million)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Escalating global prevalence of antimicrobial resistance and multi-drug resistant pathogens
- Accelerated regulatory approvals and strategic pipeline enhancements
- Integration of AI and precision medicine platforms in drug discovery
- Economic disincentives and commercial viability deficits
- Complex regulatory pathways and stringent approval standards
- Vulnerabilities within global active pharmaceutical ingredient supply chains
- Impact of drivers and challenges in 2025 and 2030
- Shift toward narrow-spectrum and pathogen-targeted therapeutics
- Integration of rapid diagnostics with precision antimicrobial protocols
- Exploration of alternative modalities beyond conventional small-molecule antibiotics
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Business segments
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Segment focus
- SWOT
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key news
- Astellas Pharma Inc. - Key offerings
- SWOT
- Aurobindo Pharma Ltd. - Overview
- Aurobindo Pharma Ltd. - Business segments
- Aurobindo Pharma Ltd. - Key news
- Aurobindo Pharma Ltd. - Key offerings
- Aurobindo Pharma Ltd. - Segment focus
- SWOT
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- Dr. Reddys Laboratories Ltd. - Overview
- Dr. Reddys Laboratories Ltd. - Business segments
- Dr. Reddys Laboratories Ltd. - Key news
- Dr. Reddys Laboratories Ltd. - Key offerings
- Dr. Reddys Laboratories Ltd. - Segment focus
- SWOT
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Business segments
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
- Gilead Sciences Inc. - Segment focus
- SWOT
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- Johnson and Johnson - Overview
- Johnson and Johnson - Business segments
- Johnson and Johnson - Key news
- Johnson and Johnson - Key offerings
- Johnson and Johnson - Segment focus
- SWOT
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Segment focus
- SWOT
- Sandoz Group AG - Overview
- Sandoz Group AG - Business segments
- Sandoz Group AG - Key news
- Sandoz Group AG - Key offerings
- Sandoz Group AG - Segment focus
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Application
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Antimicrobial Therapeutics Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Application - Market share 2025-2030 (%)
Exhibit 39: Data Table on Application - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Application
Exhibit 41: Data Table on Comparison by Application
Exhibit 42: Chart on Antiviral - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Antiviral - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Antiviral - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Antiviral - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Antibacterial - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Antibacterial - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Antibacterial - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Antibacterial - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Antifungal - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Antifungal - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Antifungal - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Antifungal - Year-over-year growth 2025-2030 (%)
Exhibit 54: Chart on Antiparasitic - Market size and forecast 2025-2030 ($ million)
Exhibit 55: Data Table on Antiparasitic - Market size and forecast 2025-2030 ($ million)
Exhibit 56: Chart on Antiparasitic - Year-over-year growth 2025-2030 (%)
Exhibit 57: Data Table on Antiparasitic - Year-over-year growth 2025-2030 (%)
Exhibit 58: Market opportunity by Application ($ million)
Exhibit 59: Data Table on Market opportunity by Application ($ million)
Exhibit 60: Chart on End-user - Market share 2025-2030 (%)
Exhibit 61: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 62: Chart on Comparison by End-user
Exhibit 63: Data Table on Comparison by End-user
Exhibit 64: Chart on Pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Research and academic institutes - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Research and academic institutes - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Research and academic institutes - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Research and academic institutes - Year-over-year growth 2025-2030 (%)
Exhibit 76: Market opportunity by End-user ($ million)
Exhibit 77: Data Table on Market opportunity by End-user ($ million)
Exhibit 78: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 79: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 80: Chart on Comparison by Route of Administration
Exhibit 81: Data Table on Comparison by Route of Administration
Exhibit 82: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Intravenous - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Intravenous - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Intravenous - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Intravenous - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Topical - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Topical - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 94: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 98: Market opportunity by Route of Administration ($ million)
Exhibit 99: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 101: Chart on Market share by geography 2025-2030 (%)
Exhibit 102: Data Table on Market share by geography 2025-2030 (%)
Exhibit 103: Chart on Geographic comparison
Exhibit 104: Data Table on Geographic comparison
Exhibit 105: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 107: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 108: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 109: Chart on Regional Comparison - North America
Exhibit 110: Data Table on Regional Comparison - North America
Exhibit 111: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Regional Comparison - Europe
Exhibit 128: Data Table on Regional Comparison - Europe
Exhibit 129: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Regional Comparison - Asia
Exhibit 158: Data Table on Regional Comparison - Asia
Exhibit 159: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 188: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 189: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 221: Market opportunity by geography ($ million)
Exhibit 222: Data Tables on Market opportunity by geography ($ million)
Exhibit 223: Impact of drivers and challenges in 2025 and 2030
Exhibit 224: Overview on criticality of inputs and factors of differentiation
Exhibit 225: Overview on factors of disruption
Exhibit 226: Impact of key risks on business
Exhibit 227: Companies covered
Exhibit 228: Company ranking index
Exhibit 229: Matrix on companies position and classification
Exhibit 230: AbbVie Inc. - Overview
Exhibit 231: AbbVie Inc. - Business segments
Exhibit 232: AbbVie Inc. - Key news
Exhibit 233: AbbVie Inc. - Key offerings
Exhibit 234: AbbVie Inc. - Segment focus
Exhibit 235: SWOT
Exhibit 236: Astellas Pharma Inc. - Overview
Exhibit 237: Astellas Pharma Inc. - Product / Service
Exhibit 238: Astellas Pharma Inc. - Key news
Exhibit 239: Astellas Pharma Inc. - Key offerings
Exhibit 240: SWOT
Exhibit 241: Aurobindo Pharma Ltd. - Overview
Exhibit 242: Aurobindo Pharma Ltd. - Business segments
Exhibit 243: Aurobindo Pharma Ltd. - Key news
Exhibit 244: Aurobindo Pharma Ltd. - Key offerings
Exhibit 245: Aurobindo Pharma Ltd. - Segment focus
Exhibit 246: SWOT
Exhibit 247: Bayer AG - Overview
Exhibit 248: Bayer AG - Business segments
Exhibit 249: Bayer AG - Key news
Exhibit 250: Bayer AG - Key offerings
Exhibit 251: Bayer AG - Segment focus
Exhibit 252: SWOT
Exhibit 253: Cipla Inc. - Overview
Exhibit 254: Cipla Inc. - Business segments
Exhibit 255: Cipla Inc. - Key news
Exhibit 256: Cipla Inc. - Key offerings
Exhibit 257: Cipla Inc. - Segment focus
Exhibit 258: SWOT
Exhibit 259: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 260: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 261: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 262: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 263: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 264: SWOT
Exhibit 265: F. Hoffmann La Roche Ltd. - Overview
Exhibit 266: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 267: F. Hoffmann La Roche Ltd. - Key news
Exhibit 268: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 269: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 270: SWOT
Exhibit 271: Gilead Sciences Inc. - Overview
Exhibit 272: Gilead Sciences Inc. - Business segments
Exhibit 273: Gilead Sciences Inc. - Key news
Exhibit 274: Gilead Sciences Inc. - Key offerings
Exhibit 275: Gilead Sciences Inc. - Segment focus
Exhibit 276: SWOT
Exhibit 277: GlaxoSmithKline Plc - Overview
Exhibit 278: GlaxoSmithKline Plc - Business segments
Exhibit 279: GlaxoSmithKline Plc - Key news
Exhibit 280: GlaxoSmithKline Plc - Key offerings
Exhibit 281: GlaxoSmithKline Plc - Segment focus
Exhibit 282: SWOT
Exhibit 283: Johnson and Johnson - Overview
Exhibit 284: Johnson and Johnson - Business segments
Exhibit 285: Johnson and Johnson - Key news
Exhibit 286: Johnson and Johnson - Key offerings
Exhibit 287: Johnson and Johnson - Segment focus
Exhibit 288: SWOT
Exhibit 289: Merck and Co. Inc. - Overview
Exhibit 290: Merck and Co. Inc. - Business segments
Exhibit 291: Merck and Co. Inc. - Key news
Exhibit 292: Merck and Co. Inc. - Key offerings
Exhibit 293: Merck and Co. Inc. - Segment focus
Exhibit 294: SWOT
Exhibit 295: Pfizer Inc. - Overview
Exhibit 296: Pfizer Inc. - Business segments
Exhibit 297: Pfizer Inc. - Key news
Exhibit 298: Pfizer Inc. - Key offerings
Exhibit 299: Pfizer Inc. - Segment focus
Exhibit 300: SWOT
Exhibit 301: Sandoz Group AG - Overview
Exhibit 302: Sandoz Group AG - Business segments
Exhibit 303: Sandoz Group AG - Key news
Exhibit 304: Sandoz Group AG - Key offerings
Exhibit 305: Sandoz Group AG - Segment focus
Exhibit 306: SWOT
Exhibit 307: Teva Pharmaceutical Ltd. - Overview
Exhibit 308: Teva Pharmaceutical Ltd. - Business segments
Exhibit 309: Teva Pharmaceutical Ltd. - Key news
Exhibit 310: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 311: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 312: SWOT
Exhibit 313: Viatris Inc. - Overview
Exhibit 314: Viatris Inc. - Business segments
Exhibit 315: Viatris Inc. - Key news
Exhibit 316: Viatris Inc. - Key offerings
Exhibit 317: Viatris Inc. - Segment focus
Exhibit 318: SWOT
Exhibit 319: Inclusions checklist
Exhibit 320: Exclusions checklist
Exhibit 321: Currency conversion rates for US$
Exhibit 322: Research methodology
Exhibit 323: Information sources
Exhibit 324: Data validation
Exhibit 325: Validation techniques employed for market sizing
Exhibit 326: Data synthesis
Exhibit 327: 360 degree market analysis
Exhibit 328: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Application
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Antimicrobial Therapeutics Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Application - Market share 2025-2030 (%)
Exhibit 39: Data Table on Application - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Application
Exhibit 41: Data Table on Comparison by Application
Exhibit 42: Chart on Antiviral - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Antiviral - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Antiviral - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Antiviral - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Antibacterial - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Antibacterial - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Antibacterial - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Antibacterial - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Antifungal - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Antifungal - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Antifungal - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Antifungal - Year-over-year growth 2025-2030 (%)
Exhibit 54: Chart on Antiparasitic - Market size and forecast 2025-2030 ($ million)
Exhibit 55: Data Table on Antiparasitic - Market size and forecast 2025-2030 ($ million)
Exhibit 56: Chart on Antiparasitic - Year-over-year growth 2025-2030 (%)
Exhibit 57: Data Table on Antiparasitic - Year-over-year growth 2025-2030 (%)
Exhibit 58: Market opportunity by Application ($ million)
Exhibit 59: Data Table on Market opportunity by Application ($ million)
Exhibit 60: Chart on End-user - Market share 2025-2030 (%)
Exhibit 61: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 62: Chart on Comparison by End-user
Exhibit 63: Data Table on Comparison by End-user
Exhibit 64: Chart on Pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Research and academic institutes - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Research and academic institutes - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Research and academic institutes - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Research and academic institutes - Year-over-year growth 2025-2030 (%)
Exhibit 76: Market opportunity by End-user ($ million)
Exhibit 77: Data Table on Market opportunity by End-user ($ million)
Exhibit 78: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 79: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 80: Chart on Comparison by Route of Administration
Exhibit 81: Data Table on Comparison by Route of Administration
Exhibit 82: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Intravenous - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Intravenous - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Intravenous - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Intravenous - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Topical - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Topical - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 94: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 98: Market opportunity by Route of Administration ($ million)
Exhibit 99: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 101: Chart on Market share by geography 2025-2030 (%)
Exhibit 102: Data Table on Market share by geography 2025-2030 (%)
Exhibit 103: Chart on Geographic comparison
Exhibit 104: Data Table on Geographic comparison
Exhibit 105: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 107: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 108: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 109: Chart on Regional Comparison - North America
Exhibit 110: Data Table on Regional Comparison - North America
Exhibit 111: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Regional Comparison - Europe
Exhibit 128: Data Table on Regional Comparison - Europe
Exhibit 129: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Regional Comparison - Asia
Exhibit 158: Data Table on Regional Comparison - Asia
Exhibit 159: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 188: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 189: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 221: Market opportunity by geography ($ million)
Exhibit 222: Data Tables on Market opportunity by geography ($ million)
Exhibit 223: Impact of drivers and challenges in 2025 and 2030
Exhibit 224: Overview on criticality of inputs and factors of differentiation
Exhibit 225: Overview on factors of disruption
Exhibit 226: Impact of key risks on business
Exhibit 227: Companies covered
Exhibit 228: Company ranking index
Exhibit 229: Matrix on companies position and classification
Exhibit 230: AbbVie Inc. - Overview
Exhibit 231: AbbVie Inc. - Business segments
Exhibit 232: AbbVie Inc. - Key news
Exhibit 233: AbbVie Inc. - Key offerings
Exhibit 234: AbbVie Inc. - Segment focus
Exhibit 235: SWOT
Exhibit 236: Astellas Pharma Inc. - Overview
Exhibit 237: Astellas Pharma Inc. - Product / Service
Exhibit 238: Astellas Pharma Inc. - Key news
Exhibit 239: Astellas Pharma Inc. - Key offerings
Exhibit 240: SWOT
Exhibit 241: Aurobindo Pharma Ltd. - Overview
Exhibit 242: Aurobindo Pharma Ltd. - Business segments
Exhibit 243: Aurobindo Pharma Ltd. - Key news
Exhibit 244: Aurobindo Pharma Ltd. - Key offerings
Exhibit 245: Aurobindo Pharma Ltd. - Segment focus
Exhibit 246: SWOT
Exhibit 247: Bayer AG - Overview
Exhibit 248: Bayer AG - Business segments
Exhibit 249: Bayer AG - Key news
Exhibit 250: Bayer AG - Key offerings
Exhibit 251: Bayer AG - Segment focus
Exhibit 252: SWOT
Exhibit 253: Cipla Inc. - Overview
Exhibit 254: Cipla Inc. - Business segments
Exhibit 255: Cipla Inc. - Key news
Exhibit 256: Cipla Inc. - Key offerings
Exhibit 257: Cipla Inc. - Segment focus
Exhibit 258: SWOT
Exhibit 259: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 260: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 261: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 262: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 263: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 264: SWOT
Exhibit 265: F. Hoffmann La Roche Ltd. - Overview
Exhibit 266: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 267: F. Hoffmann La Roche Ltd. - Key news
Exhibit 268: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 269: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 270: SWOT
Exhibit 271: Gilead Sciences Inc. - Overview
Exhibit 272: Gilead Sciences Inc. - Business segments
Exhibit 273: Gilead Sciences Inc. - Key news
Exhibit 274: Gilead Sciences Inc. - Key offerings
Exhibit 275: Gilead Sciences Inc. - Segment focus
Exhibit 276: SWOT
Exhibit 277: GlaxoSmithKline Plc - Overview
Exhibit 278: GlaxoSmithKline Plc - Business segments
Exhibit 279: GlaxoSmithKline Plc - Key news
Exhibit 280: GlaxoSmithKline Plc - Key offerings
Exhibit 281: GlaxoSmithKline Plc - Segment focus
Exhibit 282: SWOT
Exhibit 283: Johnson and Johnson - Overview
Exhibit 284: Johnson and Johnson - Business segments
Exhibit 285: Johnson and Johnson - Key news
Exhibit 286: Johnson and Johnson - Key offerings
Exhibit 287: Johnson and Johnson - Segment focus
Exhibit 288: SWOT
Exhibit 289: Merck and Co. Inc. - Overview
Exhibit 290: Merck and Co. Inc. - Business segments
Exhibit 291: Merck and Co. Inc. - Key news
Exhibit 292: Merck and Co. Inc. - Key offerings
Exhibit 293: Merck and Co. Inc. - Segment focus
Exhibit 294: SWOT
Exhibit 295: Pfizer Inc. - Overview
Exhibit 296: Pfizer Inc. - Business segments
Exhibit 297: Pfizer Inc. - Key news
Exhibit 298: Pfizer Inc. - Key offerings
Exhibit 299: Pfizer Inc. - Segment focus
Exhibit 300: SWOT
Exhibit 301: Sandoz Group AG - Overview
Exhibit 302: Sandoz Group AG - Business segments
Exhibit 303: Sandoz Group AG - Key news
Exhibit 304: Sandoz Group AG - Key offerings
Exhibit 305: Sandoz Group AG - Segment focus
Exhibit 306: SWOT
Exhibit 307: Teva Pharmaceutical Ltd. - Overview
Exhibit 308: Teva Pharmaceutical Ltd. - Business segments
Exhibit 309: Teva Pharmaceutical Ltd. - Key news
Exhibit 310: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 311: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 312: SWOT
Exhibit 313: Viatris Inc. - Overview
Exhibit 314: Viatris Inc. - Business segments
Exhibit 315: Viatris Inc. - Key news
Exhibit 316: Viatris Inc. - Key offerings
Exhibit 317: Viatris Inc. - Segment focus
Exhibit 318: SWOT
Exhibit 319: Inclusions checklist
Exhibit 320: Exclusions checklist
Exhibit 321: Currency conversion rates for US$
Exhibit 322: Research methodology
Exhibit 323: Information sources
Exhibit 324: Data validation
Exhibit 325: Validation techniques employed for market sizing
Exhibit 326: Data synthesis
Exhibit 327: 360 degree market analysis
Exhibit 328: List of abbreviations
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Astellas Pharma Inc.
- Aurobindo Pharma Ltd.
- Basilea Pharmaceutica Ltd.
- Bayer AG
- Cipla Inc.
- Dr. Reddys Laboratories Ltd.
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- Hikma Pharmaceuticals Plc
- Innoviva Inc.
- Johnson and Johnson
- Melinta Therapeutics LLC
- Merck and Co. Inc.
- Paratek Pharmaceuticals Inc.
- Pfizer Inc.
- Sandoz Group AG
- SHIONOGI Co. Ltd.
- Sun Pharmaceutical Industries
- Teva Pharmaceutical Ltd.
- Viatris Inc.
- Wockhardt Ltd.
